Here, we performed a retrospective analysis to determine the imaging features and metastatic patterns of advanced RET+ NSCLC, specifically as compared to those of ALK+ and ROS1+ NSCLC, the most common oncogenic fusions in lung cancer. The gene discussed is ROS1; the disease is non-small cell lung carcinoma.